InvestorsHub Logo
Followers 79
Posts 1668
Boards Moderated 0
Alias Born 08/26/2008

Re: biopharm post# 202241

Monday, 01/12/2015 6:47:02 AM

Monday, January 12, 2015 6:47:02 AM

Post# of 346542
Biopharm interesting


Regarding MRI w/contrast, gadolinium-based contrast agents.



To address the need for an MRI contrast agent that demonstrates greater effectiveness and lower toxicity, Dr. Sitharaman developed a novel high-performance graphene-based contrast agent that may replace the gadolinium-based agent which is widely used by physicians today. “A graphene-based contrast agent can allow the same clinical MRI performance at substantially lower dosages,” said Dr. Sitharaman.



Then the below is a must read for those like myself who has and continue to undergo MRI's w/contrast.


http://articles.mercola.com/sites/articles/archive/2014/01/09/gadolinium-mri-contrast-agent.aspx

HALF and HALF
Bavituximab and (?) So the music plays on!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News